N. Scott Fine's most recent trade in Cyclo Therapeutics Inc - Ordinary Shares - Class A was a trade of 266,354 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 266,354 | 266,354 | - | - | Stock Option (Right to Buy) | |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Apr 2023 | 299,402 | 299,402 | - | - | Warrant to Purchase Common Stock | |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 20 Apr 2023 | 299,402 | 444,402 | - | 0.7 | 212,575 | Common Stock |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 98,706 | 98,706 | - | - | Stock Option (Right to buy) | |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 74,907 | 74,907 | - | - | Stock Options (Right to buy) | |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.58 per share. | 07 Feb 2022 | 10,334 | 145,000 | - | 3.6 | 36,996 | Common Stock |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.89 per share. | 19 Jan 2022 | 5,000 | 134,666 | - | 3.9 | 19,450 | Common Stock |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.89 per share. | 15 Dec 2021 | 5,000 | 129,666 | - | 3.9 | 19,450 | Common Stock |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.93 per share. | 02 Dec 2021 | 5,000 | 124,666 | - | 4.9 | 24,650 | Common Stock |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 19 Nov 2021 | 5,000 | 119,666 | - | 5.3 | 26,250 | Common Stock |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.35 per share. | 15 Sep 2021 | 5,000 | 114,666 | - | 6.4 | 31,750 | Common Stock |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2021 | 57,300 | 57,300 | - | - | Stock Option (Right to buy) | |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 10,000 | 109,666 | - | 0 | Common Stock | |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Dec 2020 | 20,000 | 99,666 | - | - | Common Stock | |
| Cyclo Therapeutics Inc - O... | N. Scott Fine | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Dec 2020 | 20,000 | 20,000 | - | - | Warrant to Purchase Common Stock |